NorthWest Biotherapeutics Inc (NWBO)

[Extremist223]

It makes no sense to have 900 million shares out in the hands of retails, with only 20 mil short and no institutional investors. Especially on a therapy coming from UCLA, with revised endpoints in the East. Plus people paying out of pocket successfully. It's the most read stock for years on end.

What are the chances that retail longs did better DD than large firms?

All of us are pooled into NWBO, but the institutions aren't shorting? We are many fish in one barrel and they aren't making a decision to move in either direction??

So they aren't long AND they aren't short currently on Liau's life work?

I find it hard to believe and way easier to believe that all the numbers reported are trash.